Comment
doi: 10.1016/S1470-2045(20)30087-5.
Epub 2020 Mar 9.
FOLFOXIRI reintroduction in metastatic colorectal cancer
Affiliations
- PMID: 32164907
- DOI: 10.1016/S1470-2045(20)30087-5
Item in Clipboard
Comment
FOLFOXIRI reintroduction in metastatic colorectal cancer
Lancet Oncol.
2020 Apr.
No abstract available
Comment on
-
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9. Lancet Oncol. 2020. PMID: 32164906 Clinical Trial.
Similar articles
-
FOLFOXIRI and bevacizumab in metastatic colorectal cancer.Lancet Oncol. 2014 Dec;15(13):e590. doi: 10.1016/S1470-2045(14)71112-X. Epub 2014 Oct 31. Lancet Oncol. 2014. PMID: 25499288 No abstract available.
-
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.Lancet Oncol. 2015 Oct;16(13):1306-15. doi: 10.1016/S1470-2045(15)00122-9. Epub 2015 Aug 31. Lancet Oncol. 2015. PMID: 26338525 Clinical Trial.
-
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.N Engl J Med. 2014 Oct 23;371(17):1609-18. doi: 10.1056/NEJMoa1403108. N Engl J Med. 2014. PMID: 25337750 Clinical Trial.
-
[A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer].Nihon Rinsho. 2011 Apr;69 Suppl 3:439-45. Nihon Rinsho. 2011. PMID: 22214001 Review. Japanese. No abstract available.
-
FOLFOXIRI plus biologics in advanced colorectal cancer.Expert Opin Biol Ther. 2019 May;19(5):411-422. doi: 10.1080/14712598.2019.1595580. Epub 2019 Mar 27. Expert Opin Biol Ther. 2019. PMID: 30887844 Review.
Cited by
-
Notum palmitoleoyl-protein carboxylesterase regulates Fas cell surface death receptor-mediated apoptosis via the Wnt signaling pathway in colon adenocarcinoma.Bioengineered. 2021 Dec;12(1):5241-5252. doi: 10.1080/21655979.2021.1961657. Bioengineered. 2021. PMID: 34402722 Free PMC article.
-
Obesity-Associated Colorectal Cancer.Int J Mol Sci. 2024 Aug 14;25(16):8836. doi: 10.3390/ijms25168836. Int J Mol Sci. 2024. PMID: 39201522 Free PMC article. Review.
-
Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.JAMA Netw Open. 2021 Sep 1;4(9):e2124766. doi: 10.1001/jamanetworkopen.2021.24766. JAMA Netw Open. 2021. PMID: 34505885 Free PMC article.
-
Transcriptomic Landscape of Paclitaxel-Induced Multidrug Resistance in 3D Cultures of Colon Cancer Cell Line DLD1.Int J Mol Sci. 2025 Jul 9;26(14):6580. doi: 10.3390/ijms26146580. Int J Mol Sci. 2025. PMID: 40724830 Free PMC article.
-
FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells.Cancers (Basel). 2022 Sep 30;14(19):4812. doi: 10.3390/cancers14194812. Cancers (Basel). 2022. PMID: 36230735 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
